Table 3. Overall survival (OS), hepatic progression-free survival (PFS) and PFS after radioembolization.

Clinical response	Time from treatment
OS
Median (months)	31 (27–unreached)
1-year (%)	80.4 (70.6–91.5)
2-year (%)	65.6 (53.8–80.1)
Hepatic PFS
Median (months)	18 [13–27]
1-year (%)	63.2 (51.8–77.1)
2-year (%)	37.7 (26.6–53.5)
PFS
Median (months)	13 [8–19]
1-year (%)	50.6 (39.2–65.1)
2-year (%)	27.8 (18.1–42.7)